Microcurrent Treatment for Chronic Debilitating Pain

Overseen By Jill M Clark, MBA

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: Paul Crawford

Compensation: Varies

Number of Visits: 7

Duration: 6 weeks

200 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial compares standard pain treatment with and without microcurrent therapy in primary care patients. It aims to see if microcurrent therapy can be more effective in reducing pain by using tiny electrical currents to stimulate healing. Microcurrent therapy has been studied for its potential to increase function and decrease pain in people with acute knee pain.

Eligibility Criteria

Inclusion Criteria

**Patients must be able to get care at Nellis Air Force Base (a military installation) in order to participate in this study**

PROMIS-57 T score is 60 or above

Male and female Active Duty members and DoD beneficiaries

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either standard treatment with placebo or standard treatment with microcurrent therapy once a week for 6 weeks

6 weeks

6 visits (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

6 weeks

1 visit (in-person)

Treatment Details

Interventions

• Microcurrent Therapy
• Placebo

Participant Groups

Group I: Standard treatment + Microcurrent Therapy Experimental Treatment 1 Intervention

100-300µA microcurrent delivered for 20-300 minutes, once a week for 6 weeks

Group II: Standard treatment + placebo Placebo Group 1 Intervention

Placing the microcurrent pads on the patient but not turning on the microcurrent box for 30 minutes once a week for 6 weeks

Who Is Running the Clinical Trial?

Paul Crawford

Lead Sponsor

Trials

6

Recruited

970+